FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Elliot Frohman

Research Profile

Disorders

Procedures

Optical Coherence Tomography

Concepts & Ideas

Magnetic Resonance Imaging

Physiology

Anatomy

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Chris L Ayers; Khrishen Cunnusamy; Elliot M Frohman; Benjamin M Greenberg; Jason P Mendoza; Sushmita Sinha; Nitin J Karandikar
Modulation of immune function occurs within hours of therapy initiation for multiple sclerosis.
Elias S Sotirchos; Laura J Balcer; Gita Byraiah; Ciprian M Crainiceanu; Elliot M Frohman; Mohamed A Ibrahim; Michael Levy; Maureen A Mealy; Scott Douglas Newsome; Quan Dong Nguyen; John Nolan Ratchford; Shiv Saidha; Yasir Jamal Sepah; Peter A Calabresi
In vivo identification of morphologic retinal abnormalities in neuromyelitis optica.
Benjamin E Dillon; Elliot M Frohman; Benjamin Greenberg; Dominic Lee; Casey A Seideman; Gary E Lemack
A surprisingly low prevalence of demonstrable stress urinary incontinence and pelvic organ prolapse in women with multiple sclerosis followed at a tertiary neurogenic bladder clinic.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Elliot Frohman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Chris L Ayers; Khrishen Cunnusamy; Elliot M Frohman; Benjamin M Greenberg; Jason P Mendoza; Sushmita Sinha; Nitin J Karandikar
Modulation of immune function occurs within hours of therapy initiation for multiple sclerosis.
Clinical immunology (Orlando, Fla.) 2013;147(2):105-19.
2013: Elias S Sotirchos; Laura J Balcer; Gita Byraiah; Ciprian M Crainiceanu; Elliot M Frohman; Mohamed A Ibrahim; Michael Levy; Maureen A Mealy; Scott Douglas Newsome; Quan Dong Nguyen; John Nolan Ratchford; Shiv Saidha; Yasir Jamal Sepah; Peter A Calabresi
In vivo identification of morphologic retinal abnormalities in neuromyelitis optica.
Neurology 2013;80(15):1406-14.
2013: Benjamin E Dillon; Elliot M Frohman; Benjamin Greenberg; Dominic Lee; Casey A Seideman; Gary E Lemack
A surprisingly low prevalence of demonstrable stress urinary incontinence and pelvic organ prolapse in women with multiple sclerosis followed at a tertiary neurogenic bladder clinic.
The Journal of urology 2013;189(3):976-9.
2013: Shin C Beh; Teresa Frohman; Benjamin M Greenberg; Elliot M Frohman
Transverse myelitis.
Neurologic clinics 2013;31(1):79-138.
2013: John Nolan Ratchford; Shiv Saidha; Michaela A Seigo; Elias S Sotirchos; Laura J Balcer; Amy Conger; Mary K Durbin; Christopher Eckstein; Elliot M Frohman; Teresa C Frohman; Scott A Meyer; Scott Douglas Newsome; Jonathan D Oakley; Jiwon A Oh; Peter A Calabresi
Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning.
Neurology 2013;80(1):47-54.
2012: Paul Blazek; Peter A Calabresi; Amy Conger; Darrel Conger; Scott L Davis; Teresa C Frohman; Ari Green; Benjamin M Greenberg; John Nolan Ratchford; Shiv Saidha; Olaf Stuve; Steven Vernino; Laura J Balcer; Shin Beh; Elliot M Frohman
Objective characterization of the relative afferent pupillary defect in MS.
Journal of the neurological sciences 2012;323(1-2):193-200.
2012: Shiv Saidha; Michaela A Seigo; Yasir J Sepah; Elias S Sotirchos; Laura J Balcer; Ciprian M Crainiceanu; Elliot M Frohman; Jeffrey M Gelfand; Ari J Green; Mohamed A Ibrahim; Scott Douglas Newsome; Quan Dong Nguyen; Jiwon Oh; John Nolan Ratchford; Peter A Calabresi
Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study.
Lancet neurology 2012;11(11):963-72.
2012: Michaela A Seigo; Elias S Sotirchos; Stephanie B Syc; Aleksandra Babiarz; Laura J Balcer; Peter A Calabresi; Christopher Eckstein; E'tona Ford; Elliot M Frohman; Teresa C Frohman; Scott Douglas Newsome; Jonathan D Oakley; John Nolan Ratchford; Shiv Saidha
In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques.
Journal of neurology 2012;259(10):2119-30.
2012: Sara J Ireland; Monica Blazek; Laurie S Davis; Elliot M Frohman; Benjamin Greenberg; Christopher T Harp; Nancy L Monson
Antibody-independent B cell effector functions in relapsing remitting multiple sclerosis: clues to increased inflammatory and reduced regulatory B cell capacity.
Autoimmunity 2012;45(5):400-14.
2012: Benjamin M Greenberg; Paula Hardeman; Nitin J Karandikar; Martha Mann; Nancy L Monson; Gina Remington; Olaf Stuve; Donna Graves; Elliot M Frohman
Rituximab dosing and monitoring strategies in neuromyelitis optica patients: creating strategies for therapeutic success.
Multiple sclerosis (Houndmills, Basingstoke, England) 2012;18(7):1022-6.
2012: Scott D Walter; James A Wilson; Peter A Calabresi; Daniel J Feller; Elliot M Frohman; Kristin M Galetta; Steven L Galetta; Sam B Henderson; Hiroshi Ishikawa; Maureen G Maguire; Reiko E Sakai; Joel Schuman; Laura J Balcer
Ganglion cell loss in relation to visual disability in multiple sclerosis.
Ophthalmology 2012;119(6):1250-7.
2012: Kristin M Galetta; Steven L Galetta; Jennifer Graves; Deacon J Lile; Lauren S Talman; Peter A Calabresi; Elliot M Frohman; Laura J Balcer
Visual pathway axonal loss in benign multiple sclerosis: a longitudinal study.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2012;32(2):116-23.
2012: Shin C Beh; Elliot M Frohman
WEBINO and the return of the King's Speech.
Journal of the neurological sciences 2012;315(1-2):153-5.
2012: Stephanie B Syc; Ciprian M Crainiceanu; Mary K Durbin; E'tona Ford; Elliot M Frohman; Michael Levy; Scott A Meyer; Scott Douglas Newsome; Jonathan D Oakley; John Nolan Ratchford; Shiv Saidha; Peter A Calabresi
Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis.
Brain : a journal of neurology 2012;135(Pt 2):521-33.
2011: Shiv Saidha; Stephanie B Syc; Amy Conger; Mary K Durbin; Christopher Eckstein; Elliot M Frohman; Teresa C Frohman; Scott A Meyer; Scott Douglas Newsome; Jonathan D Oakley; John Nolan Ratchford; Peter A Calabresi
Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness.
Multiple sclerosis (Houndmills, Basingstoke, England) 2011;17(12):1449-63.
2011: Emma C Davies; Elliot M Frohman; Kristin M Galetta; Steven L Galetta; David J Sackel; Lauren S Talman; Peter A Calabresi; Laura J Balcer
Retinal ganglion cell layer volumetric assessment by spectral-domain optical coherence tomography in multiple sclerosis: application of a high-precision manual estimation technique.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2011;31(3):260-4.
2011: Stacy L Pineles; David J Sackel; Lauren S Talman; Eileen E Birch; Peter A Calabresi; Elliot M Frohman; Steven L Galetta; Maureen G Maguire; Laura J Balcer
One eye or two: a comparison of binocular and monocular low-contrast acuity testing in multiple sclerosis.
American journal of ophthalmology 2011;152(1):133-40.
2011: S B Syc; C V Warner; S Saidha; S K Farrell; A Conger; E R Bisker; J Wilson; Teresa C Frohman; Elliot M Frohman; Laura J Balcer; Peter A Calabresi
Cup to disc ratio by optical coherence tomography is abnormal in multiple sclerosis.
Journal of the neurological sciences 2011;302(1-2):19-24.
2011: Teresa C Frohman; Donna Graves; Benjamin Greenberg; John Hart; Gary Lemack; Diana Logan; Jeffrey Ortstadt; Gina Remington; Anjali Shah; Olaf Stuve; Katherine Treadaway; Jaspreet Abraham; Thomas Abraham; Wanda Castro; Ardith Courtney; Scott L Davis; Elliot M Frohman
Symptomatic therapy in multiple sclerosis.
Therapeutic advances in neurological disorders 2011;4(2):83-98.
2011: Ethan J Baughman; Jason P Mendoza; Sterling B Ortega; Chris L Ayers; Benjamin M Greenberg; Elliot M Frohman; Nitin J Karandikar
Neuroantigen-specific CD8+ regulatory T-cell function is deficient during acute exacerbation of multiple sclerosis.
Journal of autoimmunity 2011;36(2):115-24.
2011: Shiv Saidha; Stephanie B Syc; Mohamed A Ibrahim; Christopher Eckstein; Christina V Warner; Sheena K Farrell; Jonathan D Oakley; Mary K Durbin; Scott A Meyer; Laura J Balcer; Elliot M Frohman; Jason M Rosenzweig; Scott Douglas Newsome; John Nolan Ratchford; Quan Dong Nguyen; Peter A Calabresi
Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography.
Brain : a journal of neurology 2011;134(Pt 2):518-33.
2011: Erik V Burton; Benjamin M Greenberg; Elliot M Frohman
Optic neuritis: A mechanistic view.
Pathophysiology : the official journal of the International Society for Pathophysiology / ISP 2011;18(1):81-92.
2011: Christina V Warner; Aleksandra M Stankiewicz; Stephanie B Syc; Laura J Balcer; Esther R Bisker; Peter A Calabresi; Amy Conger; Ciprian M Crainiceanu; Sheena K Farrell; Elliot M Frohman; Teresa C Frohman; Girish Hiremath; Shiv Saidha
The impact of utilizing different optical coherence tomography devices for clinical purposes and in multiple sclerosis trials.
PloS one 2011;6(8):e22947.
2011: Kristin M Galetta; Peter A Calabresi; Elliot M Frohman; Laura J Balcer
Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2011;8(1):117-32.
2010: Olaf Stüve; Bernd C Kieseier; Bernhard Hemmer; Hans-Peter Hartung; Amer Awad; Elliot M Frohman; Benjamin M Greenberg; Michael K Racke; Scott S Zamvil; J Theodore Phillips; Ralf Gold; Andrew Chan; Uwe Zettl; Ron Milo; Ellen Marder; OA Khan; Todd N Eagar
Translational research in neurology and neuroscience 2010: multiple sclerosis.
Archives of neurology 2010;67(11):1307-15.
2010: D Cettomai; G Hiremath; John Nolan Ratchford; Arun Venkatesan; B M Greenberg; John McGready; CARLOS PARDO-VILLAMIZAR; Douglas A Kerr; Elliot M Frohman; Laura J Balcer; justin charles mcarthur; Peter A Calabresi
Associations between retinal nerve fiber layer abnormalities and optic nerve examination.
Neurology 2010;75(15):1318-25.
2010: Christopher T Harp; Sara Ireland; Laurie S Davis; Gina Remington; Bonnie Cassidy; Petra D Cravens; Olaf Stuve; Amy E Lovett-Racke; Todd N Eagar; Benjamin M Greenberg; Michael K Racke; Lindsay G Cowell; Nitin J Karandikar; Elliot M Frohman; Nancy L Monson
Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4(+) T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein.
European journal of immunology 2010;40(10):2942-56.
2010: A J Ligocki; L Lovato; D Xiang; P Guidry; Richard Scheuermann; S N Willis; S Almendinger; Michael K Racke; Elliot M Frohman; D A Hafler; K C O'Connor; Nancy L Monson
A unique antibody gene signature is prevalent in the central nervous system of patients with multiple sclerosis.
Journal of neuroimmunology 2010;226(1-2):192-3.
2010: Clemens Warnke; Til Menge; Hans-Peter Hartung; Michael K Racke; Petra D Cravens; Jeffrey Bennett; Elliot M Frohman; Benjamin M Greenberg; Scott S Zamvil; Ralf Gold; Bernhard Hemmer; Bernd C Kieseier; Olaf Stüve
Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided?
Archives of neurology 2010;67(8):923-30.
2010: Stephanie B Syc; Christina V Warner; Girish S Hiremath; Sheena K Farrell; John Nolan Ratchford; Amy Conger; Teresa C Frohman; Gary R Cutter; Laura J Balcer; Elliot M Frohman; Peter A Calabresi
Reproducibility of high-resolution optical coherence tomography in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2010;16(7):829-39.
2010: Lauren S Talman; Esther R Bisker; David J Sackel; David A Long; Kristin M Galetta; John Nolan Ratchford; Deacon J Lile; Sheena K Farrell; Michael J Loguidice; Gina Remington; Amy Conger; Teresa C Frohman; Dina A Jacobs; Clyde E Markowitz; Gary R Cutter; Gui-Shuang Ying; Yang Dai; Maureen G Maguire; Steven L Galetta; Elliot M Frohman; Peter A Calabresi; Laura J Balcer
Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis.
Annals of neurology 2010;67(6):749-60.
2010: Benjamin M Greenberg; Elliot M Frohman
Optical coherence tomography as a potential readout in clinical trials.
Therapeutic advances in neurological disorders 2010;3(3):153-60.
2010: Elliot M Frohman; Laura J Balcer; Peter A Calabresi
Multiple sclerosis: can retinal imaging accurately detect optic neuritis?
Nature reviews. Neurology 2010;6(3):125-6.
2010: Elliot M Frohman; Benjamin M Greenberg
Pearls: multiple sclerosis.
Seminars in neurology 2010;30(1):97-101.
2010: Elliot M Frohman; Gary R Cutter; Gina Remington; Hongjiang Gao; Howard Rossman; Bianca Weinstock-Guttman; Jacqueline E Durfee; Amy Conger; Ellen Carl; Katherine Treadaway; Eric Lindzen; Amber Salter; Teresa C Frohman; Anjali Shah; Angela Bates; Jennifer L Cox; Michael G Dwyer; Olaf Stüve; Benjamin M Greenberg; Michael K Racke; Robert Zivadinov
A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis.
Therapeutic advances in neurological disorders 2010;3(1):15-28.
2010: Gina M Remington; Katherine Treadaway; Teresa C Frohman; Amber Salter; Olaf Stüve; Michael K Racke; Kathleen Hawker; Federica Agosta; Maria Pia Sormani; Massimo Filippi; Elliot M Frohman
A one-year prospective, randomized, placebo-controlled, quadruple-blinded, phase II safety pilot trial of combination therapy with interferon beta-1a and mycophenolate mofetil in early relapsing-remitting multiple sclerosis (TIME MS).
Therapeutic advances in neurological disorders 2010;3(1):3-13.
2009: Rehana Z Hussain; Steven C Hopkins; Elliot M Frohman; Todd N Eagar; Petra C Cravens; Benjamin M Greenberg; Steven Vernino; Olaf Stüve
Direct and consensual murine pupillary reflex metrics: establishing normative values.
Autonomic neuroscience : basic & clinical 2009;151(2):164-7.
2009: Bryn M Burkholder; Benjamin Osborne; Michael J Loguidice; Esther Bisker; Teresa C Frohman; Amy Conger; John Nolan Ratchford; Christina Warner; Clyde E Markowitz; Dina A Jacobs; Steven L Galetta; Gary R Cutter; Maureen G Maguire; Peter A Calabresi; Laura J Balcer; Elliot M Frohman
Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis.
Archives of neurology 2009;66(11):1366-72.
2009: Elizabeth Cameron; Sade Spencer; Jonathan Lazarini; Christopher T Harp; E Sally Ward; Mark Burgoon; Gregory P Owens; Michael K Racke; Jeffrey L Bennett; Elliot M Frohman; Nancy L Monson
Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis.
Journal of neuroimmunology 2009;213(1-2):123-30.
2009: Maria del Pilar Martin; Petra D Cravens; Ryan Winger; Bernd C Kieseier; Sabine Cepok; Todd N Eagar; Scott S Zamvil; Martin S Weber; Elliot M Frohman; Betty K Kleinschmidt-Demasters; Thomas J Montine; Bernhard Hemmer; Christina M Marra; Olaf Stüve
Depletion of B lymphocytes from cerebral perivascular spaces by rituximab.
Archives of neurology 2009;66(8):1016-20.
2009: Elliot M Frohman; Michael G Dwyer; Teresa C Frohman; Jennifer L Cox; Amber Salter; Benjamin M Greenberg; Sara Hussein; Amy Conger; Peter A Calabresi; Laura J Balcer; Robert Zivadinov
Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study.
Journal of the neurological sciences 2009;282(1-2):96-105.
2009: L R Beeravolu; Elliot M Frohman; Teresa C Frohman; G M Remington; S Lee; MC Levin
Pearls & Oy-sters: "Not multiple sclerosis" and the changing face of HTLV-1: A case report of downbeat nystagmus.
Neurology 2009;72(24):e119-20.
2009: Katherine Treadaway; Gary R Cutter; Amber Salter; Sharon Lynch; James Simsarian; John Corboy; Douglas Jeffery; Bruce Cohen; Ken Mankowski; Joseph Guarnaccia; Lawrence Schaeffer; Roy Kanter; David Brandes; Charles Kaufman; David Duncan; Ellen Marder; Arthur Allen; John Harney; Joanna Cooper; Douglas Woo; Olaf Stüve; Michael Racke; Elliot M Frohman
Factors that influence adherence with disease-modifying therapy in MS.
Journal of neurology 2009;256(4):568-76.
2009: Ardith M Courtney; Katherine Treadaway; Gina Remington; Elliot M Frohman
Multiple sclerosis.
The Medical clinics of North America 2009;93(2):451-76, ix-x.
2009: Olaf Stüve; Petra D Cravens; Elliot M Frohman; J Theodore Phillips; G M Remington; G von Geldern; Sabine Cepok; M P Singh; J W Cohen Tervaert; M De Baets; D MacManus; D H Miller; E W Radü; Elizabeth Cameron; Nancy L Monson; S Zhang; R Kim; Bernhard Hemmer; Michael K Racke
Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy.
Neurology 2009;72(5):396-401.
2009: Olaf Stüve; Carsten Korth; Pablo Gabatto; Elizabeth Cameron; Wei Hu; Todd N Eagar; Nancy L Monson; Elliot M Frohman; Michael K Racke; Cyrus Zabetian; Jorge R Oksenberg
Genetic polymorphism at codon 129 of the prion protein gene is not associated with multiple sclerosis.
Archives of neurology 2009;66(2):280-1.
2009: Sophie G Fletcher; Wanda Castro-Borrero; Gina Remington; Katherine Treadaway; Gary E Lemack; Elliot M Frohman
Sexual dysfunction in patients with multiple sclerosis: a multidisciplinary approach to evaluation and management.
Nature clinical practice. Urology 2009;6(2):96-107.
2009: Wei Hu; Josbert Metselaar; Li-Hong Ben; Petra D Cravens; Mahendra P Singh; Elliot M Frohman; Todd N Eagar; Michael K Racke; Bernd C Kieseier; Olaf Stüve
PEG minocycline-liposomes ameliorate CNS autoimmune disease.
PloS one 2009;4(1):e4151.
2008: Elliot M Frohman; James G Fujimoto; Teresa C Frohman; Peter A Calabresi; Gary R Cutter; Laura J Balcer
Optical coherence tomography: a window into the mechanisms of multiple sclerosis.
Nature clinical practice. Neurology 2008;4(12):664-75.
2008: Maria del Pilar Martin; Petra D Cravens; Ryan Winger; Elliot M Frohman; Michael K Racke; Todd N Eagar; Scott S Zamvil; Martin S Weber; Bernhard Hemmer; Nitin J Karandikar; B K Kleinschmidt-DeMasters; Olaf Stüve
Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab.
Archives of neurology 2008;65(12):1596-603.
2008: J Theodore Phillips; Elliot M Frohman
Natalizumab: benefit outweighs risk in selected patients with multiple sclerosis.
Therapeutic advances in neurological disorders 2008;1(3):151-3.
2008: Elliot M Frohman; Todd Eagar; Nancy Monson; Olaf Stuve; Nitin Karandikar
Immunologic mechanisms of multiple sclerosis.
Neuroimaging clinics of North America 2008;18(4):577-88, ix.
2008: Christopher T Harp; Amy E Lovett-Racke; Michael K Racke; Elliot M Frohman; Nancy L Monson
Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis.
Clinical immunology (Orlando, Fla.) 2008;128(3):382-91.
2008: D A Mills; Teresa C Frohman; S L Davis; A R Salter; S McClure; I Beatty; A Shah; Steven L Galetta; Eric Eggenberger; David S Zee; Elliot M Frohman
Break in binocular fusion during head turning in MS patients with INO.
Neurology 2008;71(6):458-60.
2008: Teresa C Frohman; Steven L Galetta; R Fox; DAVID SOLOMON; D Straumann; M Filippi; David S Zee; Elliot M Frohman
Pearls & Oy-sters: The medial longitudinal fasciculus in ocular motor physiology.
Neurology 2008;70(17):e57-67.
2008: Aaron Boster; Gilles Edan; Elliot M Frohman; Adil Javed; Olaf Stuve; Alexandros Tselis; Howard L Weiner; Bianca Weinstock-Guttman; OA Khan
Intense immunosuppression in patients with rapidly worsening multiple sclerosis: treatment guidelines for the clinician.
Lancet neurology 2008;7(2):173-83.
2008: Richard A Nash; Olaf Stuve; James D Bowen; Elliot M Frohman; Linda M Griffith; George Hutton; George H Kraft; Uday Popat; Michael K Racke; Paolo A Muraro
Autologous HSCT for advanced MS: is the glass half-empty or really half-full?
Brain : a journal of neurology 2008;131(Pt 2):e89; author reply e90.
2008: Wei Hu; Bernd C Kieseier; Elliot M Frohman; Todd N Eagar; Roger Rosenberg; Hans-Peter Hartung; Olaf Stüve
Prion proteins: physiological functions and role in neurological disorders.
Journal of the neurological sciences 2008;264(1-2):1-8.
2008: Elliot M Frohman; Fiona Costello; Olaf Stüve; Peter A Calabresi; David H Miller; Simon J Hickman; Robert Sergott; Amy Conger; Amber Salter; Kimberly H Krumwiede; Teresa C Frohman; Laura J Balcer; Robert Zivadinov
Modeling axonal degeneration within the anterior visual system: implications for demonstrating neuroprotection in multiple sclerosis.
Archives of neurology 2008;65(1):26-35.
2008: Olaf Stüve; Jeffrey Bennett; Bernhard Hemmer; Heinz Wiendl; Michael K Racke; Amit Bar-Or; Wei Hu; Robert Zivadinov; Martin S Weber; Scott S Zamvil; Maria F Pacheco; Til Menge; Hans-Peter Hartung; Bernd C Kieseier; Elliot M Frohman
Pharmacological treatment of early multiple sclerosis.
Drugs 2008;68(1):73-83.
2007: Rodney Stuart; Amy E Lovett-Racke; Elliot M Frohman; Kathleen Hawker; Michael K Racke
Genetic analysis of the exon 1 position 49 CD152 dimorphism in multiple sclerosis.
Journal of neuroimmunology 2007;191(1-2):45-50.
2007: Olaf Stüve; Todd N Eagar; Elliot M Frohman; Petra D Cravens
DNA plasmid vaccination for multiple sclerosis.
Archives of neurology 2007;64(10):1385-6.
2007: Anjali Shah; Eric Eggenberger; Robert Zivadinov; Olaf Stüve; Elliot M Frohman
Corticosteroids for multiple sclerosis: II. Application for disease-modifying effects.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2007;4(4):627-32.
2007: Elliot M Frohman; Anjali Shah; Eric Eggenberger; Luanne Metz; Robert Zivadinov; Olaf Stüve
Corticosteroids for multiple sclerosis: I. Application for treating exacerbations.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2007;4(4):618-26.
2007: Olaf Stüve; Petra D Cravens; Mahendra P Singh; Elliot M Frohman; J Theodore Phillips; Gina Remington; Wei Hu; Bernhard Hemmer; Michael J Olek; Nancy L Monson; Michael K Racke
High incidence of post-lumbar puncture headaches in patients with multiple sclerosis treated with natalizumab: role of intrathecal leukocytes.
Archives of neurology 2007;64(7):1055-6.
2007: Elliot M Frohman; Douglas A Kerr
Is neuromyelitis optica distinct from multiple sclerosis?: something for "lumpers" and "splitters".
Archives of neurology 2007;64(6):903-5.
2007: Fiona Costello; Olaf Stüve; Martin S Weber; Scott S Zamvil; Elliot M Frohman
Combination therapies for multiple sclerosis: scientific rationale, clinical trials, and clinical practice.
Current opinion in neurology 2007;20(3):281-5.
2007: Gary E Lemack; Elliot M Frohman; Priya Ramnarayan
Women with voiding dysfunction secondary to bladder outlet dyssynergia in the setting of multiple sclerosis do not demonstrate significantly elevated intravesical pressures.
Urology 2007;69(5):893-7.
2007: Doris Lambracht-Washington; Kevin C O'Connor; Elizabeth Cameron; Andrea Jowdry; E Sally Ward; Elliot M Frohman; Michael K Racke; Nancy L Monson
Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS.
Journal of neuroimmunology 2007;186(1-2):164-76.
2007: Elliot M Frohman; Olaf Stuve; David H Miller
W. Ian McDonald, MB, ChB, PhD (1933-2006): the multiple sclerosis physician-scientist of the 20th century.
Archives of neurology 2007;64(3):452-4.
2007: Olaf Stüve; Christina M Marra; Petra D Cravens; Mahendra P Singh; Wei Hu; Amy E Lovett-Racke; Nancy L Monson; J Theodore Phillips; Jan W Cohen Tervaert; Richard A Nash; Hans-Peter Hartung; Bernd C Kieseier; Michael M Racke; Elliot M Frohman; Bernhard Hemmer
Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventions.
Archives of neurology 2007;64(2):169-76.
2007: Christopher Harp; Jane Lee; Doris Lambracht-Washington; Elizabeth Cameron; Gregory Olsen; Elliot M Frohman; Michael K Racke; Nancy L Monson
Cerebrospinal fluid B cells from multiple sclerosis patients are subject to normal germinal center selection.
Journal of neuroimmunology 2007;183(1-2):189-99.
2006: Olaf Stüve; Christina M Marra; Amit Bar-Or; Masaaki Niino; Petra D Cravens; Sabine Cepok; Elliot M Frohman; J Theodore Phillips; Gabriele Arendt; Keith R Jerome; Linda Cook; Francois Grand'Maison; Bernhard Hemmer; Nancy L Monson; Michael K Racke
Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis.
Archives of neurology 2006;63(10):1383-7.
2006: Elliot M Frohman; Fiona Costello; Robert Zivadinov; Olaf Stuve; Amy Conger; Heather Winslow; Anand Trip; Teresa C Frohman; Laura J Balcer
Optical coherence tomography in multiple sclerosis.
Lancet neurology 2006;5(10):853-63.
2006: Douglas A Woo; Michael J Olek; Elliot M Frohman
Diagnosis and management of multiple sclerosis: case studies.
Neurologic clinics 2006;24(2):199-214.
2006: Gary E Lemack; Elliot M Frohman; Philippe E Zimmern; Kathleen Hawker; Priya Ramnarayan
Urodynamic distinctions between idiopathic detrusor overactivity and detrusor overactivity secondary to multiple sclerosis.
Urology 2006;67(5):960-4.
2006: Olaf Stüve; Christina M Marra; Keith R Jerome; Linda Cook; Petra D Cravens; Sabine Cepok; Elliot M Frohman; J Theodore Phillips; Gabriele Arendt; Bernhard Hemmer; Nancy L Monson; Michael K Racke
Immune surveillance in multiple sclerosis patients treated with natalizumab.
Annals of neurology 2006;59(5):743-7.
2006: Elliot M Frohman; Eva Havrdova; Fred D Lublin; F Barkhof; A Achiron; Mohammad Sharief; Olaf Stuve; Michael K Racke; Lawrence Steinman; Howard L Weiner; Michael J Olek; Robert Zivadinov; John R Corboy; Cedric S Raine; Gary R Cutter; J Richert; Massimo Filippi
Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis.
Archives of neurology 2006;63(4):614-9.
2006: Elliot M Frohman; Michael K Racke; Cedric S Raine
Multiple sclerosis--the plaque and its pathogenesis.
The New England journal of medicine 2006;354(9):942-55.
2006: Elliot M Frohman; Eva Havrdova; Barry S Levinson; Ondrej Slanar
Azathioprine myelosuppression in multiple sclerosis: characterizing thiopurine methyltransferase polymorphisms.
Multiple sclerosis (Houndmills, Basingstoke, England) 2006;12(1):108-11.
2006: Jennifer B Fisher; Dina A Jacobs; Clyde E Markowitz; Steven L Galetta; Nicholas J Volpe; M Ligia Nano-Schiavi; Monika L Baier; Elliot M Frohman; Heather Winslow; Teresa C Frohman; Peter A Calabresi; Maureen G Maguire; Gary R Cutter; Laura J Balcer
Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis.
Ophthalmology 2006;113(2):324-32.
2006: Heather Winslow; Bruce E Mickey; Elliot M Frohman
Sympathomimetic-induced kaleidoscopic visual illusion associated with a reversible splenium lesion.
Archives of neurology 2006;63(1):135-7.
2005: Elliot M Frohman; Olaf Stüve; Eva Havrdova; John R Corboy; Anat Achiron; Robert Zivadinov; Per Soelberg Sorensen; J Theodore Phillips; Brian Weinshenker; Kathleen Hawker; Hans-Peter Hartung; Lawrence Steinman; Scott S Zamvil; Bruce A C Cree; Stephen Hauser; Howard L Weiner; Michael K Racke; Massimo Filippi
Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations.
Archives of neurology 2005;62(10):1519-30.
2005: Elliot M Frohman; Massimo Filippi; Olaf Stuve; S G Waxman; John R Corboy; J Theodore Phillips; C Lucchinetti; J Wilken; Nitin J Karandikar; Bernhard Hemmer; Nancy L Monson; J De Keyser; Hans-Peter Hartung; Lawrence Steinman; J R Oksenberg; Bruce A C Cree; S Hauser; Michael K Racke
Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions.
Archives of neurology 2005;62(9):1345-56.
2005: Gary E Lemack; Kathleen Hawker; Elliot M Frohman
Incidence of upper tract abnormalities in patients with neurovesical dysfunction secondary to multiple sclerosis: analysis of risk factors at initial urologic evaluation.
Urology 2005;65(5):854-7.
2005: Nancy L Monson; Petra D Cravens; Elliot M Frohman; Kathleen Hawker; Michael K Racke
Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis.
Archives of neurology 2005;62(2):258-64.
2005: Elliot M Frohman; Teresa C Frohman; David S Zee; Roderick McColl; Steven L Galetta
The neuro-ophthalmology of multiple sclerosis.
Lancet neurology 2005;4(2):111-21.
2005: Nancy L Monson; Hans-Peter Brezinschek; Ruth I Brezinschek; Angela Mobley; Gwen K Vaughan; Elliot M Frohman; Michael K Racke; Peter E Lipsky
Receptor revision and atypical mutational characteristics in clonally expanded B cells from the cerebrospinal fluid of recently diagnosed multiple sclerosis patients.
Journal of neuroimmunology 2005;158(1-2):170-81.
2004: Cheun Ju Chen; Mia Scheufele; Maushmi Sheth; Amir M Torabi; Nick Hogan; Elliot M Frohman
Isolated relative afferent pupillary defect secondary to contralateral midbrain compression.
Archives of neurology 2004;61(9):1451-3.
2004: Elliot M Frohman; Richard B Dewey; Teresa C Frohman
An unusual variant of the dorsal midbrain syndrome in MS: clinical characteristics and pathophysiologic mechanisms.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(3):322-5.
2004: Elliot M Frohman; K Brannon; Sherry Alexander; D Sims; J Theodore Phillips; S O'Leary; Kathleen Hawker; Michael K Racke
Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and management.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(3):302-7.
2004: J Theodore Phillips; George Rice; Elliot M Frohman; Luc Vande Gaer; Thomas Scott; Judith Haas; Eric Eggenberger; Mark S Freedman; William H Stuart; Luis Cunha; Lawrence Jacobs; Joel Oger; Douglas Arnold; T Jock Murray; Mary DiBiase; Vijay Jethwa; Susan Goelz
A multicenter, open-label, phase II study of the immunogenicity and safety of a new prefilled syringe (liquid) formulation of Avonex in patients with multiple sclerosis.
Clinical therapeutics 2004;26(4):511-21.
2004: Elliot M Frohman; Kristen Brannon; Michael K Racke; Kathleen Hawker
Mycophenolate mofetil in multiple sclerosis.
Clinical neuropharmacology 2004;27(2):80-3.
2004: Kathleen Hawker; Elliot M Frohman
Multiple sclerosis.
Primary care 2004;31(1):201-26.
2004: Michael K Racke; Kathleen Hawker; Elliot M Frohman
Fatigue in multiple sclerosis: is the picture getting simpler or more complex?
Archives of neurology 2004;61(2):176-7.
2003: Kathleen Hawker; Elliot M Frohman; Michael K Racke
Levetiracetam for phasic spasticity in multiple sclerosis.
Archives of neurology 2003;60(12):1772-4.
2003: Teresa C Frohman; Elliot M Frohman; Padraig E O'Suilleabhain; A Salter; Richard B Dewey; N Hogan; Steven L Galetta; A G Lee; D Straumann; J Noseworthy; David S Zee; J Corbett; John R Corboy; V M Rivera; Phillip D Kramer
Accuracy of clinical detection of INO in MS: corroboration with quantitative infrared oculography.
Neurology 2003;61(6):848-50.
2003: Elliot M Frohman; D S Goodin; Peter A Calabresi; John R Corboy; Patricia K Coyle; M Filippi; J A Frank; Steven L Galetta; R I Grossman; Kathleen Hawker; N J Kachuck; MC Levin; J Theodore Phillips; Michael K Racke; V M Rivera; William H Stuart
The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Neurology 2003;61(5):602-11.
2003: Elliot M Frohman
Multiple sclerosis.
The Medical clinics of North America 2003;87(4):867-97, viii-ix.
2003: Elliot M Frohman; Padraig E O'Suilleabhain; Richard B Dewey; Teresa C Frohman; Phillip D Kramer
A new measure of dysconjugacy in INO: the first-pass amplitude.
Journal of the neurological sciences 2003;210(1-2):65-71.
2003: Elliot M Frohman; Phillip D Kramer; Richard B Dewey; L Kramer; Teresa C Frohman
Benign paroxysmal positioning vertigo in multiple sclerosis: diagnosis, pathophysiology and therapeutic techniques.
Multiple sclerosis (Houndmills, Basingstoke, England) 2003;9(3):250-5.
2003: Elliot M Frohman; Teresa C Frohman
Horizontal monocular saccadic failure: an unusual clinically isolated syndrome progressing to multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2003;9(1):55-8.
2002: Elliot M Frohman; Ted Phillips; Kristen Kokel; Jerry Van Pelt; Shirley O'Leary; Shelly Gross; Kathleen Hawker; Michael K Racke
Disease-modifying therapy in multiple sclerosis: strategies for optimizing management.
The neurologist 2002;8(4):227-36.
2002: Elliot M Frohman; Teresa C Frohman; Padraig E O'Suilleabhain; H Zhang; Kathleen Hawker; Michael K Racke; William H Frawley; J Theodore Phillips; Phillip D Kramer
Quantitative oculographic characterisation of internuclear ophthalmoparesis in multiple sclerosis: the versional dysconjugacy index Z score.
Journal of neurology, neurosurgery, and psychiatry 2002;73(1):51-5.
2002: Elliot M Frohman; Teresa C Frohman; Ann M Moreault
Acquired sexual paraphilia in patients with multiple sclerosis.
Archives of neurology 2002;59(6):1006-10.
2002: Nitin J Karandikar; Michael P Crawford; Xiao Yan; Robert B Ratts; Jason M Brenchley; David R Ambrozak; Amy E Lovett-Racke; Elliot M Frohman; Peter Stastny; Daniel C Douek; Richard A Koup; Michael K Racke
Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis.
The Journal of clinical investigation 2002;109(5):641-9.
2002: D S Goodin; Elliot M Frohman; G P Garmany; J Halper; W H Likosky; Fred D Lublin; D H Silberberg; William H Stuart; S van Den Noort
Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines.
Neurology 2002;58(2):169-78.
2001: Elliot M Frohman; H Zhang; Phillip D Kramer; James L Fleckenstein; Kathleen Hawker; Michael K Racke; Teresa C Frohman
MRI characteristics of the MLF in MS patients with chronic internuclear ophthalmoparesis.
Neurology 2001;57(5):762-8.
2001: Elliot M Frohman; Teresa C Frohman; James L Fleckenstein; Michael K Racke; Kathleen Hawker; Phillip D Kramer
Ocular contrapulsion in multiple sclerosis: clinical features and pathophysiological mechanisms.
Journal of neurology, neurosurgery, and psychiatry 2001;70(5):688-92.
2001: Elliot M Frohman; Nancy L Monson; Amy E Lovett-Racke; Michael K Racke
Autonomic regulation of neuroimmunological responses: implications for multiple sclerosis.
Journal of clinical immunology 2001;21(2):61-73.
2001: Michael K Racke; Kathleen Hawker; Elliot M Frohman
Multiple sclerosis and magnetic resonance imaging: advancement in linking the pictures with the progression.
Archives of neurology 2001;58(1):35-6.
2000: Elliot M Frohman; H Zhang; Richard B Dewey; Kathleen Hawker; Michael K Racke; Teresa C Frohman
Vertigo in MS: utility of positional and particle repositioning maneuvers.
Neurology 2000;55(10):1566-9.
2000: Elliot M Frohman; M Racke; S van Den Noort
To treat, or not to treat: the therapeutic dilemma of idiopathic monosymptomatic demyelinating syndromes.
Archives of neurology 2000;57(7):930-2.